Marchex, Inc.MCHXNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank28
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
-5.24%
↓ 119% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
-2.39%
Historical baseline
PeriodValue
Q3 2025-5.24%
Q2 2025-6.36%
Q1 2025-5.95%
Q4 2024-8.56%
Q3 2024-3.63%
Q2 2024-0.68%
Q1 20242.89%
Q4 2023-19.99%
Q3 2023-3.76%
Q2 2023-1.63%
Q1 20238.44%
Q4 20228.97%
Q3 2022-0.20%
Q2 20222.05%
Q1 202222.56%
Q4 2021-11.17%
Q3 2021-33.64%
Q2 2021-10.02%
Q1 20212.96%
Q4 20200.04%
Q3 2020-2.64%
Q2 2020-0.95%
Q1 2020-1.13%
Q4 20195.53%
Q3 20192.60%
Q2 20199.57%
Q1 201913.04%
Q4 20184.66%
Q3 2018-0.31%
Q2 20186.17%
Q1 2018-14.87%
Q4 20170.68%
Q3 2017-0.63%
Q2 2017-18.73%
Q1 2017-19.99%
Q4 2016-3.59%
Q3 2016-9.57%
Q2 20161.11%
Q1 20160.30%
Q4 2015-4.11%